Irena Saarinen
Papers
1
Total Citations
6
H-Index
1
About
Irena Saarinen is a leading researcher in oncologic imaging, with a primary focus on improving the detection and staging of prostate cancer. Her most cited work, a prospective study from 2025, directly compares the diagnostic accuracy of 18F-PSMA-1007 PET/CT and whole-body MRI with diffusion-weighted imaging against histopathology as the gold standard. This research is pivotal for refining non-invasive methods to identify intraprostatic tumors and determine T-stage in high-risk patients. Saarinen’s contributions extend beyond clinical imaging; she also investigates the biological correlation between PSMA uptake on PET scans and PSMA expression measured by immunohistochemistry, bridging radiology and pathology. With 6 citations on this key paper, her work is gaining traction for its potential to guide more precise treatment planning. By validating advanced imaging techniques against definitive tissue analysis, Saarinen is helping to reduce unnecessary biopsies and improve risk stratification. Her research stands at the forefront of precision oncology, offering clinicians robust tools to visualize aggressive disease and tailor interventions, ultimately aiming to enhance outcomes for men with high-risk prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1